on AMOEBA (EPA:ALMIB)
Amoéba announces a video conference for investors on December 1, 2025
Amoéba, specializing in natural microbiological solutions, will hold a videoconference on December 1, 2025, at 6:00 p.m. Executives Benoît Villers and Jean-François Doucet will present the company's recent regulatory and commercial developments. In Europe, approval has been obtained for the biocontrol active substance, as well as marketing authorization in the United States for AXPERA. Furthermore, partnerships have been signed with Koppert, Metron Technology, and Syngenta.
This session will include a presentation of the 2026 strategy and a Q&A session. Registration is required to participate. Amoéba, listed on Euronext Growth, continues its international development in the microbiological treatment and cosmetics sectors.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all AMOEBA news